Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
Lilly set to begin critical Alimta patent dispute, WSJ says
The Fly on the Wall
Mon, 08/19/13 - 09:46 am
Eli Lilly
patents
Alimta
non-small cell lung cancer
Cancer Breakthrough Could Mean Big Gains for This Pharma Giant
Yahoo/Street Authority
Wed, 08/14/13 - 09:13 am
lung cancer
Eli Lilly
necitumumab
non-small cell lung cancer
Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition
Seeking Alpha
Mon, 08/12/13 - 09:11 am
Merck
generics
lambrolizumab
Odanacatib
melanoma
osteoporosis
non-small cell lung cancer
Ariad Pharma denied FDA's coveted 'breakthrough' stamp for lung cancer drug
Fierce Biotech
Fri, 08/9/13 - 10:00 am
Ariad Pharmaceuticals
FDA
non-small cell lung cancer
AP26113
FDA approves GILOTRIF™ (afatinib) as first-line treatment for metastatic non-small cell lung cancer with common EGFR mutations
Sacramento Bee, CA
Sat, 07/13/13 - 12:37 pm
non-small cell lung cancer
Gilotrif
Afatinib
Boehringer Ingelheim
Roche's Tarceva Progresses in Japan
Yahoo/Zacks
Tue, 06/18/13 - 08:59 am
Japan
Roche
Tarceva
non-small cell lung cancer
Clovis / CO-1686: Value, Derived From Data, Supports The Valuation
Seeking Alpha
Wed, 06/12/13 - 09:07 am
CO-1686
Clovis Oncology
non-small cell lung cancer
Synta Pharmaceuticals: A Promising Biotech Stock for 2013
Motley Fool
Tue, 06/4/13 - 11:13 am
Synta Pharmaceuticals
ganetespib
non-small cell lung cancer
NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
Yahoo/PR Newswire
Sat, 06/1/13 - 12:19 pm
NewLink Genetics
tergenpumatucel-L
non-small cell lung cancer
Encouraging News for Peregrine Pharma
Yahoo/Zacks
Sat, 05/25/13 - 11:34 am
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
lung cancer
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials
Bloomberg
Thu, 05/16/13 - 10:33 am
AstraZeneca
moxetumomab pasudotox
hairy cell leukemia
olaparib
ovarian cancer
selumetinib
non-small cell lung cancer
Bristol-Myers Has The Future Of Oncology Therapies
Seeking Alpha
Sun, 05/5/13 - 11:00 am
Bristol-Myers Squibb
nivolumab
BMS-936558
non-small cell lung cancer
renal cell carcinoma
melanoma
Ono Pharmaceutical
tivozanib
Aveo Pharmaceuticals
elotuzumab
Array's Up-Coming Value Enhancing Catalysts
Seeking Alpha
Wed, 04/17/13 - 10:50 am
Array Biopharma
Amgen
Novartis
AstraZeneca
selumetinib
MEK162
melanoma
non-small cell lung cancer
ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers
Seeking Alpha
Sun, 04/14/13 - 12:16 pm
non-small cell lung cancer
Immunogen
IMGN289
head and neck cancer
ARIAD presents new preclinical data on ponatinib
The Fly on the Wall
Mon, 04/8/13 - 11:38 am
Ariad Pharmaceuticals
Ponatinib
medullary thyroid cancer
non-small cell lung cancer
Merrimack lung cancer drug fails goal in one mid-stage trial group
Reuters
Thu, 04/4/13 - 09:22 am
lung cancer
Merrimack Pharmaceuticals
MM-121
non-small cell lung cancer
FDA seeks to fast track Novartis lung cancer drug
Reuters
Fri, 03/15/13 - 11:10 am
FDA
fast track
Novartis
non-small cell lung cancer
LDK378
FDA fast tracks two new lung cancer drugs
PM Live
Fri, 01/18/13 - 10:17 am
fast track
FDA
Boehringer Ingelheim
Astellas
Roche
Afatinib
Tarceva
non-small cell lung cancer
BI's cancer drug afatinib gets US fast-track review
Pharma Times, UK
Wed, 01/16/13 - 08:38 am
Afatinib
Boehringer Ingelheim
fast track
non-small cell lung cancer
Peregrine Recovers As Phase II Trial Is Salvaged
Seeking Alpha
Wed, 01/9/13 - 09:31 am
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
next ›
last »